Key Technologies Impacting the Future of Healthcare Industry

Microbiome Technologies, Optogenetics, Personalized Genomics and Targeted Drug Delivery Emerge as Key Game Changers as Traditional Delivery Models Collapse

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

Technological advancements are disrupting the healthcare industry. There is an increasing trend toward personalized and precise medical treatments, such as personalized genomics, which provide outputs at a much lower cost and at a faster speed than has ever been possible. Precision medicine has also driven the development of targeted drug delivery, which improves the efficacy of drugs, while reducing side effects. The increasing occurrence of auto-immune disorders has spurred research interest in microbiome therapies, which focus on using the body's own microbiota as a defense against pathogens. Another hot technology area revolutionizing neuroscience is optogenetics, which attempts to rewire the brain through the use of optics and genetics. The success of optogenetics in vision recovery has provided an impetus for funding in this space. The rising incidence of chronic and lifestyle disorders, along with the difficulty of finding donors, has led to research in printing live tissue, currently used in pharma for toxicology testing. Long-term R&D in this space is geared toward the development of 3D printed organs, which truly represent the next frontier in healthcare advancement.

However, just as technologies are disrupting healthcare, the reverse can be said to hold true. Healthcare is moving toward increased patient empowerment, leading to the development of wearables, mHealth and telemedicine. Advances in Big Data and Cloud Computing have enabled more real-time healthcare solutions such as biosensors, leading to greater patient engagement. Digital transformation has also been key to enabling path-breaking development in genomics platforms, such as rapid genome sequencing. Organizations are moving toward new care delivery models that increasingly focus on delivering patient value, leading to redefined revenue pathways. This research service provides a deep-dive analysis into some of the most disruptive technologies, trends and business models impacting healthcare today, providing decision-makers with key insights for strategic planning.

Table of Contents

1.0 Executive Summary1.1 Scope of Research1.2 Research Methodology1.3 Emerging Business Models Transforming the Healthcare Industry1.4 Key Success Factors for Adoption of a Business Model1.5 Emerging Technologies Transforming Healthcare2.0 Industry Overview2.1 Market Snapshot2.2 Healthcare Market Predictions3.0 Technology and Market Trends3.1 Smartphones, Apps and Wearables Increase Patient Empowerment3.2 A Move Toward Personalized, Value-based Medicine3.3 Trending Healthcare Applications4.0 The biggest Game Changers in Healthcare4.1.1 The Gut Microbiome Could Lead to New Therapies4.1.2 Continuous Patenting Activity in 20154.1.3 Harnessing Commercial Value from Microbiomes4.1.4 Next-gen Microbiome Technologies4.1.5 Biotech Companies in the Microbiome Space4.1.6 From Personalized Medicine to More Resistant Crops4.2 Optogenetics4.2.1 Technology for Mapping and Repairing the Brain4.2.2 Promising Results in Treating Blindness Spur Funding4.2.3 A Revolutionary Neuroscience Research Tool4.2.4 Innovations Span Diverse Application Areas4.2.5 Global Competitive Landscape4.2.6 Best Practices Business Models4.3 Personalized Genomics4.3.1 Big Data Analytics is Key to Enabling Personalized Genomics4.3.2 VCs on the Lookout for Cutting-edge Technologies in Genetic Testing4.3.3 Pharmacogenomics is a Key Application Area4.3.4 Innovations in Personalized Genome Diagnostics Abound4.3.5 Cancer Testing is an Important Focus Area for Innovators4.3.6 Direct-to-Consumer Genome Tests Gaining Traction4.4 Targeted Drug Delivery4.4.1 Advances in Nanotechnology Drive the Market4.4.2 The Demand for Precision Medicine Drives Funding and IP4.4.3 Oncology is the Most Promising Research Area4.4.4 New-Age Drug Delivery Technologies Thrive4.4.5 Several Peptides in Clinical Trials for Cell-Specific Delivery4.4.6 Business Models Target Early and Clinical-stage Pharma, Research Centers4.5 3D Bioprinting4.5.1 Changing the Face of Regenerative Medicine4.5.2 Organovo and University of Missouri Are Key Patent Holders4.5.3 3D Printed Tissue Effective for Drug and Toxicity Testing4.5.4 Skin Models Are Being Developed for Cosmetic Testing4.5.5 Key Market Players: From Medical Implants to Artificial Skin 4.5.6 Emerging Business Models: A Paradigm Shift4.6 Point-of-Care Diagnostic Devices4.6.1 Instant and Reliable Results without Requiring a Lab4.6.2 Patent Trends Cover Diverse Technology Areas4.6.3 Trending Applications: Over-the-Counter (OTC) Test Kits and Prescription-based Kits4.6.4 Key Innovations in Point-of-Care Diagnostic Devices4.6.5 Many Market Players in the PoC Space with no Clear Leader4.6.6 Business Models Will Continue to Focus on Customer Empowerment4.7 mHealth and Telemedicine4.7.1 The Rise of the Mobile Health Consumer4.7.2 Technological Advances Will Enable More At-home Care4.7.3 mHealth is Necessary for Increased Patient Engagement4.7.4 Expanding Reimbursement Options Boost Telemedicine 4.7.5 Market Dynamics across Key Sectors4.7.6 Value-based Business Models Focus on Patient Satisfaction4.8 Wearables4.8.1 Convenience Drives Adoption for Consumers and Businesses4.8.2 Diabetes is an Important Wearables Funding Focus4.8.3 Key Enabling Technologies4.8.3 Key Enabling Technologies (continued)4.8.4 Trending Applications4.8.5 Innovations in Wearables Focus on Real-time Intervention4.8.6 Global Stakeholders by Enabling Technologies 4.8.7 Wearables Will be Widely Adopted within the next Two Years4.9 Biosensors4.9.1 Seamless Integration into Everyday Living4.9.2 Potential of Integrating Biosensors into Wearables Spurs Funding4.9.3 New Applications Will Emerge with Increased Integration into Enterprise Systems 4.9.4 A Move Toward More Actionable Healthcare4.9.5 NA and EU Are Key Markets with a High Demand for Home-based Devices 4.9.6 Application & Innovation Opportunities in Biosensors4.10 Cloud Computing for Healthcare4.10.1 Key Findings4.10.2 Increased Flexibility and Agility with the Cloud4.10.3 Versatility in Service and Delivery Options 4.10.4 Cloud Computing in Healthcare: An Overview4.10.5 Governments Worldwide Are Promoting the Shift to the Cloud4.10.6 Pay-per-use Business Models Help Lower Cost and Increase Adoption4.10.7 Efficient Health Information Exchange Encourages Adoption4.10.8 Platforms Aim at Reducing Costs across the Value Chain4.10.9 Enhancing Customized and Proactive Solutions4.10.10 North America is the Leader in Cloud Computing Platforms4.11 Big Data Analytics for Healthcare4.11.1 Big Data: Improving Diagnostics, Research and Patient Outcomes4.11.2 Enabling a More Efficient Use of Healthcare Resources4.11.3 A Move Toward the Internet of Me4.11.4 Trending Benefits4.11.5 More Personalized Medical Care Enabled by Big Data4.11.6 The NIH is Funding Big Data to Facilitate Data Exchange Among Researchers4.11.7 Key Innovators Focus on a Diverse Range of Applications 4.11.8 Product Development, Precision Medicine Drive Innovation4.11.9 Increased Funding and IP toward Risk and Preventive Analytics4.11.10 Applications Areas Driven by New Value Pathways4.11.11 North America Leads the Big Data Race4.11.12 The Internet of DNA is the next Frontier5.0 Technology Roadmapping5.1 Roadmap of Technologies, Applications, Customers, and Business Models – Global, 2016–20206.0 Analyst Insights6.1 Trends Transforming the Healthcare Value Chain6.2 Transformative Business Models6.3 Business Models Shaping Personalized and Precision MedicineLegal Disclaimer7.0 The Frost & Sullivan Story7.1 The Frost & Sullivan Story7.2 Value Proposition: Future of Your Company & Career7.3 Global Perspective7.4 Industry Convergence7.5 360º Research Perspective7.6 Implementation Excellence7.7 Our Blue Ocean Strategy




Related Research

Release Date : 13-Oct-17

Region : Global

Release Date : 29-Sep-17

Region : Global

Release Date : 28-Sep-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.